Stempoint Capital »

Twist Bioscience Corp shares owned by Stempoint Capital

Quarter-by-quarter ownership of Twist Bioscience Corp (TWST) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Twist Bioscience Corp

Tip: Access up to 7 years of quarterly data

All positions including Twist Bioscience Corp held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Twist Bioscience Corp by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 518k 31.72

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Twist Bioscience Corp

ARK Investment Management
William Blair Investment Management
BlackRock
Artisan Partners Limited Partnership
Vanguard Group
Edgepoint Investment
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Soleus Capital Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Thrivent Financial for Lutherans
Invesco

View all funds holding Twist Bioscience Corp